Výsledky vyhledávání - Mariano Ponz‐Sarvisé
- Zobrazuji výsledky 1 - 20 z 26
- Přejít na další stránku
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Paradigms on Immunotherapy Combinations with Chemotherapy Autor Diego Salas‐Benito, Jose Luis Pérez‐Gracia, Mariano Ponz‐Sarvisé, María E. Rodríguez-Ruiz, Iván Martínez‐Forero, Eduardo Castañón, José M. López-Picazo, Miguel F. Sanmamed, Ignacio Melero
Vydáno 2021Revisão -
8
Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer Autor P. Martin Romano, J. Šola, Juan A. Díaz-González, Á. Chopitea, Yohana Iragorri, Fernando Martínez-Regueira, Mariano Ponz‐Sarvisé, Leire Arbea, João Subtil, David Cano, Lucía Ceniceros, Jairo Legaspi, Jose Luis Hernández‐Davó, Javier Rodríguez
Vydáno 2016Artigo -
9
Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance Autor Mariano Ponz‐Sarvisé, Paul Nguewa, María J. Pajares, Jackeline Agorreta, María D. Lozano, Miriam Redrado, Rubén Pı́o, Carmen Behrens, Ignacio I. Wistuba, Carlos E. García-Franco, Jesús García‐Foncillas, Luis M. Montuenga, Alfonso Calvo, Ignacio Gil‐Bazo
Vydáno 2011Artigo -
10
TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies Autor María E. Rodríguez-Ruiz, Inmaculada Rodríguez, Lina Mayorga, Tania Labiano, Benigno Barbés, Iñaki Etxeberría, Mariano Ponz‐Sarvisé, Arantza Azpilikueta, Elixabet Bolaños, Miguel F. Sanmamed, Pedro Berraondo, Felipe A. Calvo, Mary Helen Barcellos‐Hoff, Jose Luis Pérez‐Gracia, Ignacio Melero
Vydáno 2019Artigo -
11
Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience Autor Daniel Aliseda, Pablo Martí‐Cruchaga, Gabriel Zozaya, Macarena Rodríguez‐Fraile, José Ignacio Bilbao, Alberto Benito, Antonio Martínez-Cuesta, L. López-Olaondo, Francisco Hidalgo, Mariano Ponz‐Sarvisé, Á. Chopitea, Javier Rodríguez, Mercedes Iñarrairaegui, J.I. Herrero, Fernando Pardo, Bruno Sangro, Fernando Rotellar
Vydáno 2023Artigo -
12
A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis Autor Javier Rodríguez, Eduardo Castañón, Jose Luis Pérez‐Gracia, Inmaculada Rodríguez, A. Viúdez, Carlos Alfaro, Carmen Oñate, Guiomar Pérez, Fernando Rotellar, Susana Inogès, Ascensión López-Dı́az de Cerio, L. Resano, Mariano Ponz‐Sarvisé, María E. Rodríguez-Ruiz, Á. Chopitea, Ruth Vera, Ignacio Melero
Vydáno 2018Artigo -
13
Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagers Autor Álvaro Teijeira, Itziar Miguéliz, Saray Garasa, Vaios Karanikas, Carlos Luri‐Rey, Asunta Cirella, Irene Olivera, Marta Cañamero, Maite Álvarez, María C. Ochoa, Ana Rouzaut, María E. Rodríguez-Ruiz, Miguel F. Sanmamed, Christian Klein, Pablo Umaña, Mariano Ponz‐Sarvisé, Marina Bacac, Ignacio Melero
Vydáno 2022Artigo -
14
LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth Autor Oihane Erice, Shruthi Narayanan, Iker Feliu, Rodrigo Entrialgo‐Cadierno, Antonia Malinova, Caterina Vicentini, Elizabeth Guruceaga, Pietro Delfino, Marija Trajkovic‐Arsic, Haritz Moreno, Karmele Valencia, Ester Blanco, Irati Macaya, Daniel Öhlund, Purvesh Khatri, Fernando Lecanda, Aldo Scarpa, Jens T. Siveke, Vincenzo Corbo, Mariano Ponz‐Sarvisé, Silvestre Vicent
Vydáno 2023Artigo -
15
Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer Autor Mariano Ponz‐Sarvisé, Vincenzo Corbo, Hervé Tiriac, Dannielle D. Engle, Kristopher K. Frese, Tobiloba E. Oni, Chang‐Il Hwang, Daniel Öhlund, Iok In Christine Chio, Lindsey A. Baker, Dea Filippini, Kevin Wright, Tashinga E. Bapiro, Pearl S. Huang, Paul D. Smith, Kenneth H. Yu, Duncan I. Jodrell, Youngkyu Park, David A. Tuveson
Vydáno 2019Artigo -
16
Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients Autor María E. Rodríguez-Ruiz, Jose Luis Pérez‐Gracia, Inmaculada Rodríguez, Carlos Alfaro, Carmen Oñate, G. Pérez, Ignacio Gil‐Bazo, Alberto Benito, Susana Inogès, Ascensión López‐Díaz de Cerio, Mariano Ponz‐Sarvisé, L. Resano, Pedro Berraondo, Benigno Barbés, Salvador Martín‐Algarra, Alfonso Gúrpide, Miguel F. Sanmamed, Carlos de Andrea, Andres Μ. Salazar, Ignacio Melero
Vydáno 2018Artigo -
17
Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial Autor Bruno Bockorny, Teresa Macarulla, Valerya Semenisty, Erkut Borazanci, Jaime Feliú, Mariano Ponz‐Sarvisé, David Gutiérrez Abad, Paul E. Oberstein, Angela Alistar, Andrés Muñoz, Ravit Geva, Carmen Guillén‐Ponce, Mercedes Salgado Fernández, Amnon Peled, Marya Chaney, Irit Gliko‐Kabir, Liron Shemesh-Darvish, Debby Ickowicz, Ella Sorani, Shaul Kadosh, Abi Vainstein‐Haras, Manuel Hidalgo
Vydáno 2021Artigo -
18
An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer Autor Adrián Vallejo, Naiara Perurena, Elizabeth Guruceaga, Paweł K. Mazur, Susana Martínez-Canarias, Carolina Zandueta, Karmele Valencia, Andrea Arricibita, Dana M. Gwinn, Leanne C. Sayles, Chen-Hua Chuang, Laura Guembe, Peter J. Bailey, David K. Chang, Andrew V. Biankin, Mariano Ponz‐Sarvisé, Jesper B. Andersen, Purvesh Khatri, Aline Bözec, E. Alejandro Sweet‐Cordero, Julien Sage, Fernando Lecanda, Silvestre Vicent
Vydáno 2017Artigo -
19
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer Autor Daniel Öhlund, Abram Handly-Santana, Giulia Biffi, Ela Elyada, Ana S. Almeida, Mariano Ponz‐Sarvisé, Vincenzo Corbo, Tobiloba E. Oni, Stephen Hearn, Eun Jung Lee, Iok In Christine Chio, Chang‐Il Hwang, Hervé Tiriac, Lindsey A. Baker, Dannielle D. Engle, Christine Feig, Anne Kultti, Mikala Egeblad, Douglas T. Fearon, James M. Crawford, Hans Clevers, Youngkyu Park, David A. Tuveson
Vydáno 2017Artigo -
20
FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted Autor Adrián Vallejo, Oihane Erice, Rodrigo Entrialgo‐Cadierno, Iker Feliu, Elizabeth Guruceaga, María J. Perugorría, Paula Olaizola, Alexandra Muggli, Irati Macaya, Michael R. O’Dell, Borja Ruiz‐Fernández de Córdoba, Sergio Ortiz‐Espinosa, Aram F. Hezel, Imanol Arozarena, Fernando Lecanda, Matías A. Ávila, Maite G. Fernández‐Barrena, Matthias Evert, Mariano Ponz‐Sarvisé, Diego F. Calvisi, Jesús M. Bañales, Silvestre Vicent
Vydáno 2021Artigo
Vyhledávací nástroje:
Související témata
Medicine
Cancer
Cancer research
Biology
Internal medicine
Immunology
Genetics
Cell biology
Oncology
Pancreatic cancer
Immune system
Immunotherapy
Colorectal cancer
Chemotherapy
Gene
Organoid
Biochemistry
KRAS
Lung cancer
Pathology
Adenocarcinoma
Antibody
In vitro
T cell
Abscopal effect
Adjuvant
Cancer cell
Cancer immunotherapy
Chemistry
Clinical trial